| Protein | Synonyms | Taxonomy |
|---|---|---|
| Nucleoprotein | N; Nucleocapsid protein; NC; Protein N | Severe acute respiratory syndrome coronavirus 2 |
| Spike glycoprotein | S glycoprotein; E2; Peplomer protein | Severe acute respiratory syndrome coronavirus 2 |
| Replicase polyprotein 1ab | pp1ab; ORF1ab polyprotein | Severe acute respiratory syndrome coronavirus 2 |
| Angiotensin-converting enzyme | ACE; EC 3.2.1.-; EC 3.4.15.1; Dipeptidyl carboxypeptidase I; Kininase II | Homo sapiens (human) |
| Membrane protein | M; E1 glycoprotein; Matrix glycoprotein; Membrane glycoprotein | Severe acute respiratory syndrome coronavirus 2 |
| Angiotensinogenase | Homo sapiens (human) | |
| Envelope small membrane protein | E; sM protein | Severe acute respiratory syndrome coronavirus 2 |
| ORF9b protein | ORF9b; Accessory protein 9b; ORF-9b; Protein 9b | Severe acute respiratory syndrome coronavirus 2 |
| Compound | Description |
|---|---|
| angiotensin ii, des-phe(8)- | |
| angiotensin ii | An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. |
| angiotensin i | A decapeptide that is cleaved from precursor angiotensinogen by RENIN. Angiotensin I has limited biological activity. It is converted to angiotensin II, a potent vasoconstrictor, after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. |
| cyclic guanosine monophosphate-adenosine monophosphate | |
| angiotensin i, ile(5)- |